Avvedimento, M, Cepas-Guillén, P, Ternacle, J, Urena, M, Alperi, A, Cheema, A, Veiga-Fernandez, G, Nombela-Franco, L, Vilalta, V, Esposito, G, Campelo-Parada, F, Indolfi, C, del Trigo, M, Muñoz-Garcia, A, Maneiro, N, Asmarats, L, Regueiro, A, del Val, D, Serra, V, Auffret, V, Modine, T, Bonnet, G, Mesnier, J, Suc, G, Avanzas, P, Rezaei, E, Fradejas-Sastre, V, Tirado-Conte, G, Fernández-Nofrerias, E, Franzone, A, Guitteny, T, Sorrentino, S, Oteo, JF, Nuche, J, Gutiérrez-Alonso, L, Flores-Umanzor, E, Alfonso, F, Monastyrski, A, Nolf, M, Côté, M, Mehran, R, Morice, MC, Capodanno, D, Garot, P, Rodés-Cabau, J. Validation of the Valve Academic Research Consortium High Bleeding Risk Definition in Patients Undergoing TAVR. Circulation-Cardiovascular Interventions. 2025; 18(1)DOI:10.1161/CIRCINTERVENTIONS.124.014800. PMID:39475194. IF:7.400(Q1/2D).

Tsaban, G, Perez, RV, Krychtiuk, KA, Ahrens, I, Halvorsen, S, Hassager, C, Huber, K, Schiele, F, Sionis, A, Claeys, MJ. Lipid-lowering therapy after acute coronary syndromes: a multinational European survey. CORONARY ARTERY DISEASE. 2025; 36(1)DOI:10.1097/MCA.0000000000001420. PMID:39263716. IF:2.000(Q3/6D).

Hidalgo, OB, Alonso, CM, Jaime, FJL, Carrasco, M, Hernández, MDN, Afonso, N, Lei, A, Whyms, D, Hanna, K, Aragonés, ME, Torres, M, Oliveras, J. Safety and Efficacy of the Use of pdVWF/FVIII-C in Patients with von Willebrand Disease: A Prospective, Observational, Post-Authorization Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2025; 31DOI:10.1177/10760296251327593. PMID:40079811. IF:2.000(Q3/6D).

Vilalta, N, Oñate, G, Triquell, M, Carrasco, M, Mateo, J. Acquired FXIII Deficiency Secondary to a Myelodysplastic Syndrome. HAEMOPHILIA. 2025; 31DOI:. PMID:. IF:3.000(Q2/4D).